These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10161897)

  • 21. Antitrust developments: justice proposes consent decrees with PHOs.
    Ross DC
    J Cardiovasc Manag; 1995; 6(6):14, 16. PubMed ID: 10153784
    [No Abstract]   [Full Text] [Related]  

  • 22. Developing antitrust compliance policies.
    Becker S
    Benders Health Care Law Mon; 1996 Nov; ():9-13. PubMed ID: 10162605
    [No Abstract]   [Full Text] [Related]  

  • 23. Hospital-physician collaboration and competition: the antitrust connection.
    Enders RJ
    Healthc Financ Manage; 1986 Apr; 40(4):60-8. PubMed ID: 10275461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Federal agencies issue new antitrust guidelines.
    Bentley LD
    Radiol Manage; 1995; 17(3):18, 21-3. PubMed ID: 10144825
    [No Abstract]   [Full Text] [Related]  

  • 25. Avoid the antitrust trap: providers must study the law before they partner.
    Litwak P
    Behav Healthc Tomorrow; 1999 Aug; 8(4):19-23. PubMed ID: 10557691
    [No Abstract]   [Full Text] [Related]  

  • 26. How providers can preserve mutually beneficial joint ventures.
    Hoffman SW; Olson CE; Shirilla PM
    Health Care Strateg Manage; 1992 Sep; 10(9):7-9. PubMed ID: 10121307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Government agencies soften stance on what constitutes price fixing.
    Ettinger DA; Lasser ML
    Healthc Financ Manage; 1997 Feb; 51(2):27-9. PubMed ID: 10164872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitrust rules eased, but is there an issue?
    Burda D
    Mod Healthc; 1994 Oct; 24(40):4. PubMed ID: 10137213
    [No Abstract]   [Full Text] [Related]  

  • 29. Leaping hurdles. Antitrust clearance costly, offers no guarantee: AHA.
    Carlson J
    Mod Healthc; 2011 Jun; 41(23):7, 16. PubMed ID: 21710945
    [No Abstract]   [Full Text] [Related]  

  • 30. Antitrust's expanding universe.
    Back K
    Health Syst Rev; 1996; 29(6):11-2, 14. PubMed ID: 10167137
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognosis: prison? Health care providers, as they set up new business arrangements in this era of rising medical costs, risk running afoul of federal antitrust and antifraud laws.
    Kosterlitz J
    Natl J (Wash); 1989 Jun; 21(24):1576-7, 1582-4. PubMed ID: 10293560
    [No Abstract]   [Full Text] [Related]  

  • 32. Reading the antitrust road map.
    Kaplan GL
    Provider; 1995 May; 21(5):89-90, 92. PubMed ID: 10142403
    [No Abstract]   [Full Text] [Related]  

  • 33. Legally speaking: Federal Trade Commission issues positive advisory opinions on antitrust implications of clinical integration.
    Wright R
    J Ark Med Soc; 2009 Oct; 106(4):88-9. PubMed ID: 19813398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Really special treatment. AHA seeks update on federal antitrust statements.
    Taylor M
    Mod Healthc; 2004 Jun; 34(25):8-9. PubMed ID: 15239524
    [No Abstract]   [Full Text] [Related]  

  • 35. Antitrust and joint ventures.
    Jose DE
    Top Health Care Financ; 1986; 13(1):27-40. PubMed ID: 3764895
    [No Abstract]   [Full Text] [Related]  

  • 36. Government policies on a collision course. Health cost containment and the antitrust laws.
    Mooney DJ
    Med Group Manage J; 1993; 40(5):46-8, 50, 52. PubMed ID: 10129299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The developing application of antitrust laws to hospital mergers.
    Mudge OS; Gibofsky A
    J Leg Med; 1994 Sep; 15(3):355-84. PubMed ID: 7964156
    [No Abstract]   [Full Text] [Related]  

  • 38. PHOs undergo new level of antitrust scrutiny.
    Enders RJ
    Calif Hosp; 1995; 9(3):20, 22-3. PubMed ID: 10152292
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitrust pitfalls in outpatient services.
    Hartley JE; Corwin WJ
    Med Staff Couns; 1993; 7(1):53-63. PubMed ID: 10123461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimizing antitrust exposure in a virtual merger.
    Brock TH
    Healthc Financ Manage; 1999 Sep; 53(9):38-44. PubMed ID: 11066705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.